Absci Corporation, a data-first generative AI drug creation company, and Invetx, a pioneer in protein-based therapeutics for ...

Absci (ABSI) and Invetx announced a strategic partnership to harness Absci’s AI Drug Creation models to create an innovative Half-Life ...

Collaboration leverages Absci's leading generative AI Drug Creation models to design a novel antibody Half-Life Extension (HLE) platform for animal health applications. VANCOUVER, ...